CNN/Money  
graphic
News > Companies
graphic
It's official: Pfizer buys Pharmacia
Nine months after announcement, maker of Lipitor, Viagra snags Rogaine, Celebrex, Xanax, Nicorette.
April 16, 2003: 2:52 PM EDT

NEW YORK (CNN/Money) - Pfizer said Wednesday that it officially bought Pharmacia, creating a drug company with $46 billion in annual sales and sought-after treatments for impotence, high-cholesterol, arthritis, glaucoma and depression.

The closing of the $60 deal solidifies Pfizer's lead as the No. 1 drug maker, capping a growth-by-acquisition run for Pfizer that began three years ago with its purchase of Warner-Lambert.

The new Pfizer (PFE: Research, Estimates) isn't just the largest drug company by sales. Its $256 billion market value makes it No. 3 behind only General Electric and Microsoft. At $7 billion, its research budget also tops all rivals.

But Pfizer stock has made little progress since the deal was announced last July as investors question whether a company this big can keep growing.

The merged company will hold about 11 percent of the world's market for prescription drugs, behind Britain's GlaxoSmithKline Plc, which has a 7 percent share.

Purchased in 2000, Warner Lambert offered Lipitor, the cholesterol drug that brought Pfizer an industry record $7.9 billion in sales last years.

Pharmacia brings Rogaine for hair loss and Nicorette, the gum designed to wean smokers from cigarettes. It has a glaucoma treatment, Xalatan, an anxiety treatment, Xanax, and the leading overactive bladder treatment, Detrol.

Pharmacia fills a void of Pfizer's with Camptosar, a treatment for colorectal cancer. The acquisition will also give Pfizer control over arthritis drug Celebrex, which the companies have sold jointly since 1998. It also gives Pfizer Eplerenone, a heart disease treatment.

"On any given day, we estimate that nearly 40 million people around the world are treated with a Pfizer medicine," Pfizer's Chief Executive Officer Hank McKinnell said in statement.

Fred Hassan, Pharmacia CEO, has said he will not be joining Pfizer.

Pfizer's is the biggest deal to close since Nov. 18, 2002, when Comcast competed the purchase of AT&T's broad band unit for $72 billion, according to Thomson Financial.

The closing of the deal, announced last July, was pushed back several times as Pfizer sold a series of treatments to satisfy anti-trust regulators on both sides of the Atlantic.

Click here for drug stocks

New York-based Pfizer makes Zoloft, to treat depression, and the erectile dysfunction drug Viagra, the heart drug Norvasc, and over-the-counter remedies including Rolaids, Benadryl, Listerine and Sudafed.

Pharmacia shareholders get 1.4 Pfizer shares for each Pharmacia share they own. Pfizer stock fell 53 cents to $31.68 Wednesday afternoon.

Efficiencies from the deal, Pfizer said, will save $2.5 billion in 2005.

The closing of the deal brings an end to Pharmacia, which started as a Sweden-based company and merged with U.S. drugmaker Upjohn in 1995 to become Pharmacia & Upjohn. It moved its headquarters first to England and then to Peapack, New Jersey in 1998.  Top of page


-- Reuters contributed to this report




  More on NEWS
Obama would cut deficits by another $1 trillion
Detroit pension cuts hit civilian workers hardest
NBA player to open Hooters in Russia
  TODAY'S TOP STORIES
Cool cars from the New York Auto Show
Detroit cuts hit civilian workers hardest
GM's recalled Cobalt: Failure from the start




graphic graphic
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.